Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur-Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson R

Open source

DOI
10.3310/hta17310
Published
2013 Jul
Container
Health technology assessment (Winchester, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3310/hta17310,
  title = {Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.},
  author = {Brown T and Pilkington G and Bagust A and Boland A and Oyee J and Tudur-Smith C and Blundell M and Lai M and Martin Saborido C and Greenhalgh J and Dundar Y and Dickson R},
  year = {2013},
  journal = {Health technology assessment (Winchester, England)},
  doi = {10.3310/hta17310},
  url = {https://doi.org/10.3310/hta17310}
}

RIS

TY  - JOUR
TI  - Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
AU  - Brown T
AU  - Pilkington G
AU  - Bagust A
AU  - Boland A
AU  - Oyee J
AU  - Tudur-Smith C
AU  - Blundell M
AU  - Lai M
AU  - Martin Saborido C
AU  - Greenhalgh J
AU  - Dundar Y
AU  - Dickson R
PY  - 2013
JO  - Health technology assessment (Winchester, England)
DO  - 10.3310/hta17310
UR  - https://doi.org/10.3310/hta17310
ER  - 

APA

T, B., G, P., A, B., A, B., J, O., C, T., M, B., M, L., C, M. S., J, G., Y, D., & R, D. (2013). Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.. Health technology assessment (Winchester, England). https://doi.org/10.3310/hta17310

Source records